Multifunctional liposomes improve treatment outcomes for multidrug-resistant breast cancer, suggesting a new therapeutic strategy.
To address multidrug resistance (MDR) in breast cancer, a multifunctional liposome (RID-LPs) was developed by replacing cholesterol with ginsenoside Rg3 and incorporating DSPE-PEG2000 for prolonged systemic circulation. This nanoplatform encapsulates...
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: